The Australian market has experienced a relatively stable day, with the ASX200 closing at 7,760 points and sectors such as Health Care showing positive movement while others like Staples lagged. In this context of fluctuating sector performances and strategic shifts among companies, identifying stocks that may be trading below their estimated value can present potential opportunities for investors looking to capitalize on market inefficiencies.
Name | Current Price | Fair Value (Est) | Discount (Est) |
Acrow (ASX:ACF) | A$1.05 | A$2.04 | 48.5% |
GenusPlus Group (ASX:GNP) | A$2.63 | A$5.15 | 48.9% |
Medical Developments International (ASX:MVP) | A$0.485 | A$0.89 | 45.5% |
Amaero (ASX:3DA) | A$0.23 | A$0.45 | 48.9% |
Genetic Signatures (ASX:GSS) | A$0.44 | A$0.84 | 47.6% |
Pantoro (ASX:PNR) | A$2.72 | A$5.36 | 49.2% |
Nuix (ASX:NXL) | A$2.37 | A$4.30 | 44.9% |
Integral Diagnostics (ASX:IDX) | A$2.25 | A$4.03 | 44.2% |
Electro Optic Systems Holdings (ASX:EOS) | A$1.20 | A$2.38 | 49.6% |
Select Harvests (ASX:SHV) | A$5.41 | A$9.62 | 43.8% |
Click here to see the full list of 36 stocks from our Undervalued ASX Stocks Based On Cash Flows screener.
Here we highlight a subset of our preferred stocks from the screener.
Overview: Corporate Travel Management Limited is a travel management solutions company that oversees the procurement and delivery of travel services across Australia and New Zealand, North America, Asia, and Europe, with a market cap of A$1.77 billion.
Operations: The company generates revenue through its travel services across various regions, with A$60.96 million from Asia, A$126.20 million from Europe, A$319.90 million from North America, and A$181.43 million from Australia and New Zealand.
Estimated Discount To Fair Value: 23.6%
Corporate Travel Management is trading at A$12.57, 23.6% below its estimated fair value of A$16.46, making it potentially undervalued based on cash flows. Despite a drop in profit margins from 15.3% to 9.2%, earnings are projected to grow significantly at 21.3% annually, outpacing the Australian market's growth rate of 11.7%. Recent leadership changes aim to enhance operational efficiency and client growth as Jo Sully succeeds Greg McCarthy as CEO for Australia & New Zealand by June 2025.
Overview: Nick Scali Limited, with a market cap of A$1.44 billion, is involved in the sourcing and retailing of household furniture and related accessories across Australia, the United Kingdom, and New Zealand.
Operations: The company's revenue is primarily derived from the retailing of furniture, amounting to A$492.63 million.
Estimated Discount To Fair Value: 41%
Nick Scali is trading at A$16.80, 41% below its estimated fair value of A$28.48, suggesting it may be undervalued based on cash flows. Despite a decline in net income to A$30.04 million for the half-year ending December 2024, forecasts indicate earnings growth of 12.3% annually, surpassing the Australian market average of 11.7%. The company maintains a reliable dividend yield of 3.57%, although dividends were reduced from previous levels due to decreased earnings per share.
Overview: Pantoro Limited, along with its subsidiaries, is involved in gold mining, processing, and exploration in Western Australia and has a market cap of A$1.05 billion.
Operations: The company's revenue is primarily derived from the Norseman Gold Project, amounting to A$289.11 million.
Estimated Discount To Fair Value: 49.2%
Pantoro is trading at A$2.72, significantly below its estimated fair value of A$5.36, highlighting potential undervaluation based on cash flows. Recent production results show a 30% increase in gold output to 40,812 ounces with improved sales of A$153.43 million for the half-year ending December 2024. The company has turned profitable with net income of A$6.62 million and forecasts suggest robust earnings growth ahead, supported by ongoing drilling programs at the OK Underground Mine.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include ASX:CTD ASX:NCK and ASX:PNR.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.